Compare Abeona Therapeutics Inc (ABEO) vs GraniteShares 2x Long COIN Daily ETF (CONL) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
Abeona Therapeutics Inc vs GraniteShares 2x Long COIN Daily ETF — how do they compare? Abeona Therapeutics Inc trades at $6.73 (market cap $373.32M), while GraniteShares 2x Long COIN Daily ETF trades at $5.01. The key difference: Abeona Therapeutics Inc is trading nearer its 52-week high, GraniteShares 2x Long COIN Daily ETF nearer its low. Which is the better fit depends on your goals.
| ABEO | CONL | |
|---|---|---|
Market Cap | $373.32M | — |
Sector | Health | Leveraged / Inverse |
52-Week High | $7.23 | $64.57 |
52-Week Low | $4.17 | $4.09 |
Enterprise Value | $228.22M | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ABEO trades at $6.31, down 1.41% today, with a bullish technical outlook supported by moving averages. The company reported Q1 2026 results with revenue growth and beat EPS expectations, while maintaining strong profitability margins. Recent news highlights expansion of treatment centers and new cell therapy licensing.
Outlook remains positive with analyst consensus favoring Buy ratings (66.67%), though high RSI indicates potential near-term overbought conditions. Key risks include negative operating cash flow and reliance on new treatment adoption. Upside depends on continued commercial execution and pipeline advancements.
CONL trades at $5.62, up 4.07% today but remains a highly volatile leveraged ETF tracking Coinbase stock. Technical indicators show bearish momentum with mixed oscillators, while financial ratios are unavailable for this derivative product. Recent news highlights extreme volatility, with the fund losing 67% year-to-date as daily reset leverage magnifies Coinbase price swings.
The outlook remains speculative with potential for explosive gains if Coinbase rallies, but structural risks from daily leverage reset create significant volatility decay. Investors face amplified exposure to cryptocurrency market sentiment and Coinbase performance without traditional company fundamentals to anchor valuation.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Abeona Therapeutics Inc
Abeona Therapeutics develops gene and cell therapies for rare diseases. Its lead product, ZEVASKYN, is an FDA-approved therapy for recessive dystrophic epidermolysis bullosa (RDEB), a severe and life-threatening genetic skin disorder.
Read more on ABEO →About GraniteShares 2x Long COIN Daily ETF
CONL is a leveraged ETF that seeks to provide two times (2x) the daily performance of Coinbase Global (COIN) stock. It is designed for investors seeking magnified short-term exposure to the price movements of Coinbase.
Read more on CONL →
